Boswellia 350 mg joints

Description

Boswellia 350 mg joints from Longlife is a boswellia supplement titled at 70% in boswellic acids and 2% in AKBA (acetyl-11-keto-beta-boswellic acid), useful for joint function, the digestive system and the contrast of localized stress states.

Properties and benefits of Boswellia 350 mg joints

Boswellia serrata extract has important potential effects as a preparation of plant origin, and may be an alternative to classic treatments for certain chronic inflammatory diseases.

Well known for its proven effectiveness in reducing phlogosis associated with osteoarthritis and rheumatoid arthritis, boswellia can also be indicated for allergic reactions (bronchial asthma, atopic reactions), for migraine and for inflammatory bowel diseases (in particular Crohn's disease, ulcerative colitis). It also exerts an analgesic action.

Contribute to:

• joint function
• Function of the digestive system
• Reduces localized tension

How to take Boswellia 350 mg joints?

It is recommended to take 1-3 capsules a day with meals.

Precautions

Food supplements should not be used as a substitute for a balanced and varied diet or a healthy lifestyle. Do not take if you are allergic to any of its components. Keep out of the reach of children. Do not exceed the recommended daily dose.

Storage conditions

Keep in a cool, dry place and protected from sunlight.

Composition of Boswellia 350 mg joints

Boswellia resin (Boswellia serrata Roxb.), Bulking agent (dibasic calcium phosphate), anti-caking agents (vegetable magnesium stearate, magnesium silicate and silicon dioxide). Capsule of vegetable origin in hydroxypropylmethylcellulose.

For 1 capsule:

Boswellin HBD - boswellia resin 350 mg (Boswellia serrata Roxb.) extract (5/10:1) titrated dry hydroalcoholic 70% [245 mg] total boswellic acids of which: 20% [70 mg] beta-boswellic acids 2% [7 mg] acetyl-11-keto-beta-boswellic acid (AKBA).